Back

Intensity of dual antiplatelet therapy based on thrombotic and bleeding risks after coronary stenting

26 August 2023 (13:15 - 13:45)
Organised by: Logo
Congress Presentation Part of: Risk stratification in acute coronary syndromes (2) Thrombosis, Platelets, and Coagulation ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Associate Professor Jeong-Su Kim

Pusan National University Yangsan Hospital, Yangsan (Korea (Republic of))

5 More presentations in this session

Presentation thumbnail
Impact of new-onset versus preexisting atrial fibrillation on short- and long-term mortality in patients with STEMI treated with primary PCI
Doctor M. Klaric (Belgrade, RS)
Abstract Slides Video
Presentation thumbnail
Predictive value of lung ultrasound combined with ACEF score in patients with acute myocardial infarction
Doctor Y. Zhang (Guangzhou, CN)
Abstract Slides Video
Presentation thumbnail
Reticulated platelets predict cardiovascular death and adverse events in coronary artery disease
Doctor D. Bongiovanni (Augsburg, DE)
Abstract Slides Video
Presentation thumbnail
Myocardial salvage and infarct characteristics in patients with ST-elevation myocardial infarction classified by ORBI risk score
Mr J. Kunkel (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Cholesterol-Years and the risk of the first MI
Professor M. Banach (Lodz, PL)
Abstract Slides Video

Access the full session

Session thumbnail
Risk stratification in acute coronary syndromes (2)

The Event

Event poster

ESC Congress 2023

26 August 2023 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Pattern of dual antiplatelet use and 12-month outcomes stratified by bleeding and ischemic risk in acute coronary syndrome patients undergoing percutaneous coronary intervention
thumbnail
Congress Presentation
Association between high platelet reactivity and early stent thrombosis in patients with drug-eluting stent implantation
thumbnail
Congress Presentation
Clinical impact of high platelet reactivity in patients with atrial fibrillation and concomitant percutaneous coronary intervention on dual or triple antithrombotic therapy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources